Get CEO.CA Pro
Real-time Level 2 Market Depth
Click for live demo
Get $50 Off Your First Month!
TSX, TSXV or CSE Exchanges
Sign up here

read first

Please read the CEO.CA House Rules before posting.

social

Youtube
Linkedin
Instagram

legal

Use of this site indicates acceptance of the Privacy Policy and Terms of Use.
The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
CEO.CA members discuss high-risk penny stocks which can lose their entire value. Only risk what you can afford to lose.
© 2022 - CEO.CA Technologies Ltd.
Articles
@nasdaq/curis-announces-dosing-of-first-patient-in-a-phase-1-trial-of-ca-170-the-first-oral-small-molecule-drug-candidate-to-target-and-inhibit-immune-checkpoints ↻
0 online
Today This week
Search
Members of @nasdaq/curis-announces-dosing-of-first-patient-in-a-phase-1-trial-of-ca-170-the-first-oral-small-molecule-drug-candidate-to-target-and-inhibit-immune-checkpoints
Moderators
Members
No more messages to load
to become a contributing member of the community.
Log in
Sign up
Personal channels